Minerals Technologies Inc. (MTX) Stock Price & How to Invest

Minerals Technologies Inc. (NYSE: MTX) is a global specialty minerals company built originally out of Pfizer's minerals unit. It is one of the largest producers of precipitated calcium carbonate (PCC) and the world's largest bentonite producer, and it organizes its business into two segments: Consumer & Specialties (household and personal care products such as cat litter, personal care, fabric care, edible-oil purification, plus specialty additives) at roughly 53% of sales, and Engineered Solutions (high-temperature refractory technologies and environmental and infrastructure products) at roughly 47%. The company sells into paper, packaging, construction, automotive, foundry, steel, and consumer markets across more than 35 countries.

The investment picture is one of a durable, cash-generative industrial trading at a below-market multiple while a legacy overhang gets resolved. Recent results have shown a return to profit and double-digit revenue growth, but the story is dominated by talc-related product-liability claims that MTX is channeling into a proposed $450 million trust via the Chapter 11 of subsidiary BMI OldCo, with a large associated charge booked in 2026. Owning MTX is therefore a bet that the underlying minerals franchise keeps compounding modestly while the litigation is capped and removed as an open-ended risk.

The dominant risk is the talc litigation itself: the reorganization plan must be confirmed and funded, and a large charge (around $290 million booked in 2026) already pressures reported results, with the possibility of adverse rulings or higher-than-expected claim funding. As a specialty-minerals maker, MTX is exposed to energy, freight, and raw-material cost inflation, which has recently squeezed margins amid geopolitical disruption. Its end markets (paper, construction, steel, and automotive) are cyclical and sensitive to global industrial demand and currency swings given large international exposure. Competition from larger diversified players such as Imerys and Omya can pressure pricing and share. Finally, the modest dividend yield and mid-cap size mean the equity can be volatile around litigation and macro headlines.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Minerals Technologies Inc.'s investor relations page or your broker.

• Revenue (TTM): ~$2.1B
• Market cap: ~$1.8B
• P/E ratio: ~14x
• Q1 2026 revenue: ~$547M (up ~11% YoY)
• Q1 2026 adjusted EPS: ~$1.38
• Dividend yield: ~0.6%

MTX trades at roughly 14 times earnings, a discount to the broader chemicals and materials group, which reflects the market pricing in talc-litigation uncertainty rather than weak operations. Revenue of about $2.1 billion generates operating income in the low-double-digit-percent margin range, and Q1 2026 showed both revenue growth and a profit rebound. The valuation gap is the crux of the debate: bulls see a discount that narrows once the litigation is capped, while the reported figures remain distorted by large one-time reserve charges.

There are three common ways to get MTX exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so MTX sits alongside other stocks that express the same thesis.

Walnut takes the basket route. Describe a thesis where MTX fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

MTX is a steady, mid-cap specialty-minerals maker trading at a discounted multiple, with the talc litigation resolution as the swing factor for how the market re-rates it.

Whether MTX is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is MTX a buy?, and where the stock could go from here in the MTX stock forecast.

For income investors, whether MTX pays a dividend and how the payout looks is covered in does MTX pay a dividend?